| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | Apr 03, 2024 | Sale | $4.95 | 10,451 | 51,732 | 0 | Apr 05, 2024, 04:30 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | Apr 02, 2024 | Sale | $4.98 | 150 | 747 | 10,451 | Apr 02, 2024, 04:58 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | Apr 01, 2024 | Option Exercise | $5.12 | 4,732 | 24,228 | 10,601 | Apr 02, 2024, 04:58 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | Dec 12, 2023 | Sale | $4.95 | 6,287 | 31,121 | 0 | Dec 14, 2023, 04:24 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | Dec 06, 2023 | Sale | $3.95 | 6,287 | 24,834 | 6,287 | Dec 08, 2023, 04:23 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | Nov 01, 2023 | Option Exercise | $2.22 | 6,301 | 13,988 | 12,574 | Nov 02, 2023, 04:52 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | Jul 31, 2023 | Sale | $3.95 | 7,348 | 29,025 | 0 | Aug 02, 2023, 04:21 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | Apr 03, 2023 | Option Exercise | $2.58 | 623 | 1,607 | 7,348 | Apr 04, 2023, 06:56 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Roth David | Chief Medical Officer | Apr 01, 2022 | Option Exercise | $1.12 | 27,281 | 30,555 | 59,719 | Apr 04, 2022, 05:03 PM |
Menu